Skip to content
Point32Health Provider
  • Home
  • Policies
    • Forms
    • Medical Benefit Drug Medical Necessity Guidelines
    • Medical Necessity Guidelines
    • Open Negotiation and Independent Dispute Resolution (No Surprises Act)
    • Payment Policies
    • Pharmacy
      • Formulary Lookup
      • Pharmacy Medical Necessity Guidelines
      • Pharmacy UM
      • Pharmacy Updates
      • Requesting authorization for pharmacy and medical drugs
    • Prior Authorization
      • Prior authorization resources
      • Vendor programs
    • Provider Manuals
      • Harvard Pilgrim Health Care Commercial Provider Manual
      • Stride Medicare Advantage Provider Manual
      • Tufts Health Plan Commercial Provider Manual
      • Tufts Health Public Plans Provider Manual
      • Tufts Health Plan Senior Products Provider Manual
  • Network & plans
    • Behavioral Health
    • Join the network
      • Join the Harvard Pilgrim Health Care network
      • Join the Tufts Health Plan network
    • Our Plans
      • Harvard Pilgrim products
        • Tiered network product resources
        • Stride Medicare Advantage Plan
      • Tufts Health Plan products
    • Quality Initiatives
      • HEDIS/Star tip sheets
      • Physician Group Honor Roll
    • Clinical Resources
      • Clinical Practice Guidelines
      • Mind the Moment for Providers
  • Office resources
    • Electronic services
      • HPHConnect
      • Tufts Health Plan Provider Portal
      • Electronic Data Interchange (EDI)
      • Electronic Funds Transfer (EFT)
    • Insights and Updates for Providers
    • News Center
    • Provider Training
  • Harvard Pilgrim Health Care Login
  • Tufts Health Plan Login

Medical Benefit Drug Medical Necessity Guidelines

The Medical Drug Medical Necessity Guidelines below detail coverage criteria for medical benefit drugs for Harvard Pilgrim Health Care and Tufts Health Plan lines of business. We encourage you to use the drop-down menu to filter applicability by product. We note line of business under the guideline name; however, the policy may not apply to every product in that line of business. Please refer to the policy for product applicability.

Tufts Health Together utilizes MassHealth’s Unified Formulary for pharmacy medications and select medical benefit drugs. For a list of medical benefit medications that utilize MassHealth coverage criteria, refer to the Unified Medical Policies Medical Drug Necessity Guidelines, and for the MassHealth drug coverage and criteria refer to the MassHealth Drug List.

We recommend submitting your prior authorization requests electronically via PromptPA.

Search Filters

Clear filters All Filters
  • D
  • J
  • W

Documents in this collection

Saphnelo (anifrolumab-fnia)
Public Plans; Senior Products
Saphnelo (anifrolumab-fnia)
Commercial; Public Plans
Scenesse (afamelanotide)
Public Plans; Senior Products
Scenesse (afamelanotide)
Commercial; Public Plans
Short-Acting Colony Stimulating Factors
Commercial; Public Plans Granix (tbo-filgrastim), Neupogen (filgrastim), Nivestym (filgrastim-aafi), Releuko (filgrastim-ayow), Nypozi
Skysona (elivaldogene autotemcel)
Commercial; Public Plans
Somatostatin Analogs
Tufts Health RITogether Sandostatin (octreotide), Sandostatin LAR (octreotide), Signifor LAR (pasireotide), Somatuline Depot (lanreotide), Lanreotide (Cipla)
Somatostatin Analogs for Non-oncology Indications
Commercial; Public Plans Sandostatin (octreotide), Sandostatin LAR (octreotide), Signifor LAR (pasireotide), Somatuline Depot (lanreotide), Lanreotide (Cipla)
Somatostatin Analogs for Non-Oncology Indications
Public Plans; Senior Products Sandostatin (octreotide), Sandostatin LAR (octreotide for injectable suspension), Signifor LAR (pasireotide), Somatuline Depot (lanreotide), Lanreotide (Cipla)
Somatostatin Analogs for Oncology Indications
Commercial; Public Plans Sandostatin (octreotide), Sandostatin LAR (octreotide), Somatuline Depot (lanreotide), Lanreotide (Cipla)
Somatostatin Analogs for Oncology Indications
Public Plans; Senior Products Sandostatin (octreotide), Sandostatin LAR (octreotide), Somatuline Depot (lanreotide), Lanreotide (Cipla)
Spevigo (spesolimab-sbzo)
Public Plans; Senior Products
Spevigo (spesolimab-sbzo)
Commercial; Public Plans
Spinraza (nusinersen)
Commercial; Public Plans
Spinraza (nusinersen)
Public Plans; Senior Products
Spravato (esketamine)
Tufts Health RITogether
Spravato (esketamine)
Commercial; Public Plans
Spravato (esketamine)
Public Plans; Senior Products
Sublocade (buprenorphine extendedrelease)
Tufts Health RITogether
Syfovre (pegcetacoplan injection)
Public Plans; Senior Products
Syfovre (pegcetacoplan injection)
Commercial; Public Plans
Synagis (palivizumab)
Commercial; Public Plans

Oncology Medical Management

If you are utilizing a medical drug for oncology purposes for a Harvard Pilgrim Health Care Commercial or Stride (HMO/ HMO-POS) Medicare Advantage member, prior authorization is necessary through OncoHealth. For more information, please refer to the OncoHealth link on the Medical Necessity Guidelines page and the Harvard Pilgrim vendor programs resource page.

 

Medical Drugs Available through Specialty Pharmacies

You can access a number of medical benefit drugs through specialty pharmacies. Options are detailed in the “Office-Administered Medical Drugs” policies found on this page. There are 3 versions of this policy, based on product: for Harvard Pilgrim Health Care commercial, Tufts Health Plan Commercial and Tufts Medicare Preferred, and Tufts Health Direct.

© 2025 Point32Health, Inc.

 

  • Nondiscrimination Statement
  • Website Terms of Use
  • Privacy & Security
  • Accessibility Statement
  • Contact us